Kenya has formally joined the Trial Regulation and Clinical Ethics Optimization (TRACE) Project, a continental push to speed up clinical trial approvals across Africa. The move is expected to boost the country's ability to attract medical research funding and get life-saving treatments to patients faster.
TRACE is designed to improve how quickly African nations review and approve clinical trials. It aims to make the process more transparent and efficient across the entire continent.
Nigeria, Tanzania, Rwanda and Zimbabwe were already part of the initiative. Kenya's participation creates a growing coalition of African states committed to modernising their clinical research systems.
Several Kenyan institutions are driving the effort locally. These include the National Commission for Science, Technology and Innovation, the Pharmacy and Poisons Board, the Kenya Medical Research Institute, and Moi Teaching and Referral Hospital.
Under TRACE, Kenya will introduce a parallel review system for clinical trials. Ethics committees and drug regulators will now assess applications simultaneously instead of one after the other.
Experts believe this reform could slash approval delays significantly. Many African countries have struggled with slow review processes that discourage medical research.
TRACE targets protocol reviews in less than 60 days. Patient safety and ethical standards won't be compromised, according to the consortium.
Digital systems will receive major upgrades as part of the initiative. Kenya plans to improve workflow management and introduce electronic review tools across research oversight institutions.
Africa's regulatory fragmentation has long been a problem. Slow approvals have kept African patients from accessing new medicines and vaccines available elsewhere.
By harmonising review processes, TRACE wants to make African countries attractive destinations for global clinical research. The project will also train reviewers and strengthen institutional review boards.
Progress is already evident in other participating countries. Rwanda has completed technical specifications for a national digital ethics review platform that supports parallel submissions.
Zimbabwe is building an integrated Clinical Trials and Protocol Processing System for electronic submissions. The platform will allow researchers to submit and track research protocols online.
Rwanda's review procedures for ethics oversight have been updated through the project. Nigeria is also revising its National Code of Health Research Ethics to strengthen clinical trial reviews.
Tanzania is advancing its own clinical research systems as part of the continental effort. All participating nations are working toward the same goal of faster, more efficient approvals.
